Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of interferon-alpha production (GO:0032727) | 6.55789382 |
2 | modulation by symbiont of host immune response (GO:0052553) | 6.35583271 |
3 | positive regulation by symbiont of host defense response (GO:0052509) | 6.35583271 |
4 | modulation by symbiont of host defense response (GO:0052031) | 6.35583271 |
5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.35583271 |
6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.35583271 |
7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.35583271 |
8 | regulation of interferon-alpha production (GO:0032647) | 6.18414486 |
9 | * cellular response to type I interferon (GO:0071357) | 6.05181698 |
10 | * type I interferon signaling pathway (GO:0060337) | 6.05181698 |
11 | * response to type I interferon (GO:0034340) | 5.99787546 |
12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.67375520 |
13 | negative regulation of viral genome replication (GO:0045071) | 5.38585234 |
14 | positive regulation of type 2 immune response (GO:0002830) | 5.00491686 |
15 | response to peptidoglycan (GO:0032494) | 4.92216866 |
16 | * response to interferon-alpha (GO:0035455) | 4.91962666 |
17 | cellular response to exogenous dsRNA (GO:0071360) | 4.91401621 |
18 | negative regulation of interleukin-12 production (GO:0032695) | 4.78749734 |
19 | response to host immune response (GO:0052572) | 4.75427433 |
20 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.75427433 |
21 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.73143312 |
22 | neutrophil activation involved in immune response (GO:0002283) | 4.72970442 |
23 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.72753861 |
24 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.68393263 |
25 | positive regulation of interferon-beta production (GO:0032728) | 4.62697546 |
26 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.59949738 |
27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.56364913 |
28 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.56364913 |
29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.51641930 |
30 | regulation of RIG-I signaling pathway (GO:0039535) | 4.43621660 |
31 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.42989467 |
32 | natural killer cell mediated immunity (GO:0002228) | 4.42989467 |
33 | cellular response to interferon-beta (GO:0035458) | 4.41308813 |
34 | cellular response to virus (GO:0098586) | 4.40401416 |
35 | macrophage activation involved in immune response (GO:0002281) | 4.40050128 |
36 | immunoglobulin mediated immune response (GO:0016064) | 4.37869068 |
37 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.36356807 |
38 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.31838200 |
39 | positive regulation of T cell cytokine production (GO:0002726) | 4.23938968 |
40 | response to host (GO:0075136) | 4.21663194 |
41 | response to host defenses (GO:0052200) | 4.21663194 |
42 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.21663194 |
43 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.21555212 |
44 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.20388761 |
45 | negative regulation of cell killing (GO:0031342) | 4.20388761 |
46 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.14366200 |
47 | detection of molecule of bacterial origin (GO:0032490) | 4.13381046 |
48 | T-helper 1 type immune response (GO:0042088) | 4.10162029 |
49 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 4.04802584 |
50 | response to interferon-beta (GO:0035456) | 4.04264367 |
51 | T cell migration (GO:0072678) | 4.02790313 |
52 | regulation of type 2 immune response (GO:0002828) | 3.96645495 |
53 | lymphocyte chemotaxis (GO:0048247) | 3.91231245 |
54 | negative regulation of T cell mediated immunity (GO:0002710) | 3.90302254 |
55 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.89255288 |
56 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.87460374 |
57 | microglial cell activation (GO:0001774) | 3.81921098 |
58 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.80513894 |
59 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.77460632 |
60 | granulocyte activation (GO:0036230) | 3.74628679 |
61 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.73701541 |
62 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.70550574 |
63 | detection of other organism (GO:0098543) | 3.63393507 |
64 | positive regulation of interleukin-12 production (GO:0032735) | 3.61942436 |
65 | negative regulation of type 2 immune response (GO:0002829) | 3.60933874 |
66 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.59934391 |
67 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.59762017 |
68 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.59693461 |
69 | * defense response to virus (GO:0051607) | 3.59493055 |
70 | regulation of activation of Janus kinase activity (GO:0010533) | 3.59320397 |
71 | * cellular response to interferon-alpha (GO:0035457) | 3.58608426 |
72 | cellular response to interferon-gamma (GO:0071346) | 3.51875585 |
73 | positive regulation of interleukin-17 production (GO:0032740) | 3.50382562 |
74 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.50206698 |
75 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.48687358 |
76 | neutrophil activation (GO:0042119) | 3.47962257 |
77 | respiratory burst (GO:0045730) | 3.46320053 |
78 | natural killer cell activation involved in immune response (GO:0002323) | 3.44655024 |
79 | regulation of mononuclear cell migration (GO:0071675) | 3.44240774 |
80 | detection of external biotic stimulus (GO:0098581) | 3.41117094 |
81 | positive regulation of antigen processing and presentation (GO:0002579) | 3.40650944 |
82 | B cell mediated immunity (GO:0019724) | 3.40185729 |
83 | regulation of chemokine biosynthetic process (GO:0045073) | 3.39381979 |
84 | defense response to protozoan (GO:0042832) | 3.37591717 |
85 | regulation of interferon-beta production (GO:0032648) | 3.33965184 |
86 | myeloid cell activation involved in immune response (GO:0002275) | 3.30973062 |
87 | regulation of defense response to virus by host (GO:0050691) | 3.29885611 |
88 | monocyte chemotaxis (GO:0002548) | 3.27239185 |
89 | eosinophil chemotaxis (GO:0048245) | 3.26836995 |
90 | detection of bacterium (GO:0016045) | 3.26080056 |
91 | cellular response to zinc ion (GO:0071294) | 3.25464254 |
92 | positive regulation of lymphocyte migration (GO:2000403) | 3.25294390 |
93 | response to exogenous dsRNA (GO:0043330) | 3.24320345 |
94 | regulation of interleukin-17 production (GO:0032660) | 3.21561333 |
95 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.21081614 |
96 | negative regulation of viral process (GO:0048525) | 3.20491513 |
97 | response to interferon-gamma (GO:0034341) | 3.19728081 |
98 | regulation of viral genome replication (GO:0045069) | 3.17511708 |
99 | reactive oxygen species biosynthetic process (GO:1903409) | 3.16657413 |
100 | negative regulation of interleukin-17 production (GO:0032700) | 3.16467902 |
101 | regulation of gamma-delta T cell activation (GO:0046643) | 3.15426124 |
102 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.13533322 |
103 | positive regulation of response to biotic stimulus (GO:0002833) | 3.13413144 |
104 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.10665059 |
105 | regulation of T cell tolerance induction (GO:0002664) | 3.10303481 |
106 | response to muramyl dipeptide (GO:0032495) | 3.10244209 |
107 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.09370045 |
108 | germinal center formation (GO:0002467) | 3.08520434 |
109 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.07992312 |
110 | regulation of T cell cytokine production (GO:0002724) | 3.07912932 |
111 | regulation of toll-like receptor signaling pathway (GO:0034121) | 3.07751460 |
112 | leukocyte mediated cytotoxicity (GO:0001909) | 3.06878694 |
113 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.04845982 |
114 | macrophage activation (GO:0042116) | 3.04740716 |
115 | myeloid dendritic cell differentiation (GO:0043011) | 3.03598548 |
116 | positive regulation of heat generation (GO:0031652) | 3.03587648 |
117 | regulation of chronic inflammatory response (GO:0002676) | 3.03317301 |
118 | regulation of immunoglobulin secretion (GO:0051023) | 3.02863070 |
119 | response to protozoan (GO:0001562) | 3.01546946 |
120 | detection of biotic stimulus (GO:0009595) | 3.00459535 |
121 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.99979999 |
122 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.99977376 |
123 | NIK/NF-kappaB signaling (GO:0038061) | 2.99501974 |
124 | interferon-gamma secretion (GO:0072643) | 2.98987724 |
125 | I-kappaB phosphorylation (GO:0007252) | 2.98486214 |
126 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 2.97515432 |
127 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 2.97515432 |
128 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.96688708 |
129 | negative regulation of type I interferon production (GO:0032480) | 2.95800150 |
130 | regulation of natural killer cell differentiation (GO:0032823) | 2.95752247 |
131 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.95570236 |
132 | regulation of antigen processing and presentation (GO:0002577) | 2.94401743 |
133 | regulation of interleukin-12 production (GO:0032655) | 2.94062344 |
134 | regulation of fever generation (GO:0031620) | 2.93381496 |
135 | positive regulation of defense response to virus by host (GO:0002230) | 2.92907000 |
136 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.91235662 |
137 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.90498127 |
138 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.90234752 |
139 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.89188367 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.86344789 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 8.08144959 |
3 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 7.39646400 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.92099054 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.35424280 |
6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.50652923 |
7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.48684039 |
8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.55077178 |
9 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.49453917 |
10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.25826695 |
11 | GATA1_22025678_ChIP-Seq_K562_Human | 3.07495651 |
12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.04438302 |
13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.89254048 |
14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.88464646 |
15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.58226986 |
16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.57307432 |
17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.49116151 |
18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.38875549 |
19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.33593435 |
20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.13922535 |
21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.77087538 |
22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71752552 |
23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.57796062 |
24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55317768 |
25 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53552815 |
26 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.50958668 |
27 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50607741 |
28 | MYB_26560356_Chip-Seq_TH2_Human | 1.48030973 |
29 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47995604 |
30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.44486332 |
31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.43369420 |
32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.42140273 |
33 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31578598 |
34 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.27396575 |
35 | MAF_26560356_Chip-Seq_TH1_Human | 1.26557549 |
36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22797647 |
37 | MYB_26560356_Chip-Seq_TH1_Human | 1.22561751 |
38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.21353582 |
39 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20259107 |
40 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19565818 |
41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.18871716 |
42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17172311 |
43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14858739 |
44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13676172 |
45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.13223300 |
46 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13013561 |
47 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12261028 |
48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11613201 |
49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.10998402 |
50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10418399 |
51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10089512 |
52 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09442544 |
53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07661754 |
54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.05256899 |
55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04323906 |
56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03861410 |
57 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.01978068 |
58 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01194671 |
59 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.00891772 |
60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.99162458 |
61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95814528 |
62 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.94901334 |
63 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93504575 |
64 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92005668 |
65 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89558433 |
66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88976476 |
67 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88628735 |
68 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88628735 |
69 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87898882 |
70 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87040651 |
71 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.86558510 |
72 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.86330401 |
73 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.86159112 |
74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.86041517 |
75 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83844488 |
76 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82540611 |
77 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.82486307 |
78 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.80460562 |
79 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78156477 |
80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.76812925 |
81 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.76312925 |
82 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.75693227 |
83 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.75622888 |
84 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75503885 |
85 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.73940463 |
86 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.73281494 |
87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.72889952 |
88 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.71183494 |
89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70281554 |
90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69999406 |
91 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.69561158 |
92 | MYC_22102868_ChIP-Seq_BL_Human | 0.68658963 |
93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.68351458 |
94 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.67132023 |
95 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66079434 |
96 | UTX_26944678_Chip-Seq_JUKART_Human | 0.65479374 |
97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.64463539 |
98 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.64395818 |
99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.64274648 |
100 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.62158393 |
101 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.61288639 |
102 | MAF_26560356_Chip-Seq_TH2_Human | 0.60578055 |
103 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.60435803 |
104 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.60064496 |
105 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.59752243 |
106 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.58761462 |
107 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.56579678 |
108 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.56579678 |
109 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.56351623 |
110 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.55123519 |
111 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.54331296 |
112 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.53164723 |
113 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.52311893 |
114 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.50018905 |
115 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.48916310 |
116 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.48573914 |
117 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.48485367 |
118 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.48470775 |
119 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.47019852 |
120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.46870565 |
121 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46446218 |
122 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.45449009 |
123 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.44909645 |
124 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.44290086 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.82194563 |
2 | MP0009785_altered_susceptibility_to | 4.69283890 |
3 | MP0002148_abnormal_hypersensitivity_rea | 3.96418612 |
4 | MP0006082_CNS_inflammation | 3.92601939 |
5 | MP0003724_increased_susceptibility_to | 3.84259756 |
6 | MP0003436_decreased_susceptibility_to | 3.65703317 |
7 | MP0005000_abnormal_immune_tolerance | 3.34669136 |
8 | MP0005025_abnormal_response_to | 3.30688301 |
9 | MP0003303_peritoneal_inflammation | 3.29774728 |
10 | MP0001790_abnormal_immune_system | 3.23982489 |
11 | MP0005387_immune_system_phenotype | 3.23982489 |
12 | MP0000685_abnormal_immune_system | 3.23871104 |
13 | MP0004510_myositis | 2.98140765 |
14 | MP0002419_abnormal_innate_immunity | 2.97750106 |
15 | MP0005671_abnormal_response_to | 2.84145017 |
16 | MP0002723_abnormal_immune_serum | 2.63810502 |
17 | MP0002452_abnormal_antigen_presenting | 2.62918094 |
18 | MP0001800_abnormal_humoral_immune | 2.60261240 |
19 | MP0005058_abnormal_lysosome_morphology | 2.42706004 |
20 | MP0001533_abnormal_skeleton_physiology | 2.32127514 |
21 | MP0001819_abnormal_immune_cell | 2.21033801 |
22 | MP0009764_decreased_sensitivity_to | 2.18572800 |
23 | MP0004947_skin_inflammation | 2.17800439 |
24 | MP0002420_abnormal_adaptive_immunity | 2.12519347 |
25 | MP0005451_abnormal_body_composition | 2.05298845 |
26 | MP0008469_abnormal_protein_level | 1.91085909 |
27 | MP0003448_altered_tumor_morphology | 1.90076400 |
28 | MP0001845_abnormal_inflammatory_respons | 1.87989174 |
29 | MP0002006_tumorigenesis | 1.85514503 |
30 | MP0001853_heart_inflammation | 1.83071961 |
31 | MP0005464_abnormal_platelet_physiology | 1.79909032 |
32 | MP0003075_altered_response_to | 1.77395411 |
33 | MP0010155_abnormal_intestine_physiology | 1.70331779 |
34 | MP0000343_altered_response_to | 1.66594272 |
35 | MP0008004_abnormal_stomach_pH | 1.58006324 |
36 | MP0003172_abnormal_lysosome_physiology | 1.56285292 |
37 | MP0000716_abnormal_immune_system | 1.56182199 |
38 | MP0000604_amyloidosis | 1.55107011 |
39 | MP0004858_abnormal_nervous_system | 1.54845500 |
40 | MP0002405_respiratory_system_inflammati | 1.50628635 |
41 | MP0005310_abnormal_salivary_gland | 1.49966256 |
42 | MP0002166_altered_tumor_susceptibility | 1.48774076 |
43 | MP0009278_abnormal_bone_marrow | 1.46247927 |
44 | MP0004782_abnormal_surfactant_physiolog | 1.44446625 |
45 | MP0008260_abnormal_autophagy | 1.43896807 |
46 | MP0002398_abnormal_bone_marrow | 1.43533815 |
47 | MP0002139_abnormal_hepatobiliary_system | 1.38165279 |
48 | MP0003191_abnormal_cellular_cholesterol | 1.37090152 |
49 | MP0002998_abnormal_bone_remodeling | 1.35936598 |
50 | MP0005167_abnormal_blood-brain_barrier | 1.33552401 |
51 | MP0009840_abnormal_foam_cell | 1.32631801 |
52 | MP0009333_abnormal_splenocyte_physiolog | 1.32570158 |
53 | MP0010307_abnormal_tumor_latency | 1.30388893 |
54 | MP0005164_abnormal_response_to | 1.29204153 |
55 | MP0000858_altered_metastatic_potential | 1.26374928 |
56 | MP0005397_hematopoietic_system_phenotyp | 1.26140331 |
57 | MP0001545_abnormal_hematopoietic_system | 1.26140331 |
58 | MP0002277_abnormal_respiratory_mucosa | 1.24720454 |
59 | MP0006054_spinal_hemorrhage | 1.24569397 |
60 | MP0005166_decreased_susceptibility_to | 1.20957925 |
61 | MP0002429_abnormal_blood_cell | 1.20508807 |
62 | MP0009763_increased_sensitivity_to | 1.11271887 |
63 | MP0003186_abnormal_redox_activity | 1.11268100 |
64 | MP0003690_abnormal_glial_cell | 1.10218420 |
65 | MP0003806_abnormal_nucleotide_metabolis | 1.07924116 |
66 | MP0005390_skeleton_phenotype | 1.05749261 |
67 | MP0000689_abnormal_spleen_morphology | 1.05017254 |
68 | MP0003656_abnormal_erythrocyte_physiolo | 1.04535604 |
69 | MP0003300_gastrointestinal_ulcer | 0.99487116 |
70 | MP0002722_abnormal_immune_system | 0.97748356 |
71 | MP0003091_abnormal_cell_migration | 0.97409046 |
72 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94778622 |
73 | MP0000569_abnormal_digit_pigmentation | 0.89110885 |
74 | MP0000465_gastrointestinal_hemorrhage | 0.87521762 |
75 | MP0009765_abnormal_xenobiotic_induced | 0.85343852 |
76 | MP0002163_abnormal_gland_morphology | 0.84098420 |
77 | MP0008438_abnormal_cutaneous_collagen | 0.83017529 |
78 | MP0001348_abnormal_lacrimal_gland | 0.82505133 |
79 | MP0003866_abnormal_defecation | 0.80408855 |
80 | MP0008874_decreased_physiological_sensi | 0.80121564 |
81 | MP0003763_abnormal_thymus_physiology | 0.79317829 |
82 | MP0003045_fibrosis | 0.78356133 |
83 | MP0002332_abnormal_exercise_endurance | 0.73940599 |
84 | MP0000249_abnormal_blood_vessel | 0.71132727 |
85 | MP0001663_abnormal_digestive_system | 0.70775669 |
86 | MP0001958_emphysema | 0.69717075 |
87 | MP0002132_abnormal_respiratory_system | 0.69379970 |
88 | MP0003566_abnormal_cell_adhesion | 0.69067069 |
89 | MP0000703_abnormal_thymus_morphology | 0.68998562 |
90 | MP0001851_eye_inflammation | 0.68762979 |
91 | MP0010352_gastrointestinal_tract_polyps | 0.67278500 |
92 | MP0010386_abnormal_urinary_bladder | 0.67274238 |
93 | MP0003453_abnormal_keratinocyte_physiol | 0.66614884 |
94 | MP0002933_joint_inflammation | 0.66385431 |
95 | MP0002138_abnormal_hepatobiliary_system | 0.65601864 |
96 | MP0002254_reproductive_system_inflammat | 0.64691526 |
97 | MP0003195_calcinosis | 0.64251118 |
98 | MP0004808_abnormal_hematopoietic_stem | 0.62135385 |
99 | MP0001542_abnormal_bone_strength | 0.62086789 |
100 | MP0001501_abnormal_sleep_pattern | 0.61233886 |
101 | MP0003828_pulmonary_edema | 0.60470184 |
102 | MP0002136_abnormal_kidney_physiology | 0.60088718 |
103 | MP0005023_abnormal_wound_healing | 0.59282605 |
104 | MP0005076_abnormal_cell_differentiation | 0.58635187 |
105 | MP0008775_abnormal_heart_ventricle | 0.56181920 |
106 | MP0005165_increased_susceptibility_to | 0.55591178 |
107 | MP0001881_abnormal_mammary_gland | 0.54990926 |
108 | MP0003646_muscle_fatigue | 0.53624205 |
109 | MP0005083_abnormal_biliary_tract | 0.52894458 |
110 | MP0005376_homeostasis/metabolism_phenot | 0.52177516 |
111 | MP0000609_abnormal_liver_physiology | 0.51883202 |
112 | MP0002090_abnormal_vision | 0.50943133 |
113 | MP0003329_amyloid_beta_deposits | 0.50133554 |
114 | MP0005535_abnormal_body_temperature | 0.50092676 |
115 | MP0003795_abnormal_bone_structure | 0.49150544 |
116 | MP0005319_abnormal_enzyme/_coenzyme | 0.46377907 |
117 | MP0003183_abnormal_peptide_metabolism | 0.45909955 |
118 | MP0004883_abnormal_blood_vessel | 0.45842225 |
119 | MP0000767_abnormal_smooth_muscle | 0.45654075 |
120 | MP0001915_intracranial_hemorrhage | 0.45230388 |
121 | MP0000920_abnormal_myelination | 0.45128012 |
122 | MP0002693_abnormal_pancreas_physiology | 0.44726445 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 6.77467436 |
2 | Recurrent abscess formation (HP:0002722) | 6.67733385 |
3 | Recurrent bacterial skin infections (HP:0005406) | 6.46149352 |
4 | Autoimmune thrombocytopenia (HP:0001973) | 6.36207730 |
5 | Increased IgM level (HP:0003496) | 5.55600215 |
6 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.48523823 |
7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.17289722 |
8 | Abnormality of macrophages (HP:0004311) | 5.08161348 |
9 | Mediastinal lymphadenopathy (HP:0100721) | 4.89389074 |
10 | Basal ganglia calcification (HP:0002135) | 4.57551129 |
11 | Systemic lupus erythematosus (HP:0002725) | 4.36346018 |
12 | Chronic otitis media (HP:0000389) | 4.30124131 |
13 | Keratoconjunctivitis (HP:0001096) | 4.20154250 |
14 | Vasculitis (HP:0002633) | 4.10786572 |
15 | Stomatitis (HP:0010280) | 4.05361567 |
16 | Recurrent skin infections (HP:0001581) | 4.01373226 |
17 | Orchitis (HP:0100796) | 3.93127146 |
18 | Gingivitis (HP:0000230) | 3.85200216 |
19 | Tetraparesis (HP:0002273) | 3.83671247 |
20 | Recurrent viral infections (HP:0004429) | 3.83104643 |
21 | Myositis (HP:0100614) | 3.80364908 |
22 | Hypergammaglobulinemia (HP:0010702) | 3.76195404 |
23 | Recurrent fungal infections (HP:0002841) | 3.70715419 |
24 | Retrobulbar optic neuritis (HP:0100654) | 3.67662624 |
25 | Optic neuritis (HP:0100653) | 3.67662624 |
26 | Porencephaly (HP:0002132) | 3.65676812 |
27 | Prostate neoplasm (HP:0100787) | 3.60482497 |
28 | Interstitial pulmonary disease (HP:0006530) | 3.55358682 |
29 | Vacuolated lymphocytes (HP:0001922) | 3.47526743 |
30 | Increased cerebral lipofuscin (HP:0011813) | 3.46372775 |
31 | T lymphocytopenia (HP:0005403) | 3.35204462 |
32 | Autoimmune hemolytic anemia (HP:0001890) | 3.34916871 |
33 | Thick nail (HP:0001805) | 3.32870845 |
34 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.31100045 |
35 | Encephalitis (HP:0002383) | 3.26694360 |
36 | Periodontitis (HP:0000704) | 3.20804203 |
37 | Chronic obstructive pulmonary disease (HP:0006510) | 3.14982622 |
38 | Obstructive lung disease (HP:0006536) | 3.14982622 |
39 | Gangrene (HP:0100758) | 3.08176175 |
40 | Pustule (HP:0200039) | 3.07924030 |
41 | Nasal polyposis (HP:0100582) | 2.99302956 |
42 | Recurrent cutaneous fungal infections (HP:0011370) | 2.81565665 |
43 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.81565665 |
44 | Pulmonary infiltrates (HP:0002113) | 2.81085226 |
45 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.80468903 |
46 | Osteolytic defects of the hand bones (HP:0009699) | 2.80468903 |
47 | Poor head control (HP:0002421) | 2.77651446 |
48 | Abnormality of the nasal mucosa (HP:0000433) | 2.77646880 |
49 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.77211682 |
50 | Cellulitis (HP:0100658) | 2.74897239 |
51 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.71703638 |
52 | Gastrointestinal infarctions (HP:0005244) | 2.71537784 |
53 | Pulmonary embolism (HP:0002204) | 2.66837867 |
54 | Urticaria (HP:0001025) | 2.65565656 |
55 | Amyloidosis (HP:0011034) | 2.64840059 |
56 | Axonal loss (HP:0003447) | 2.63848513 |
57 | Premature loss of primary teeth (HP:0006323) | 2.63057308 |
58 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.61999870 |
59 | Recurrent bronchitis (HP:0002837) | 2.61709095 |
60 | Chronic sinusitis (HP:0011109) | 2.60570095 |
61 | Abnormality of the endocardium (HP:0004306) | 2.60536360 |
62 | Episodic fever (HP:0001954) | 2.60300244 |
63 | Spontaneous hematomas (HP:0007420) | 2.60030542 |
64 | Cleft eyelid (HP:0000625) | 2.54108855 |
65 | Leukocytosis (HP:0001974) | 2.52109795 |
66 | Recurrent pneumonia (HP:0006532) | 2.52101291 |
67 | Increased IgE level (HP:0003212) | 2.49372402 |
68 | Hematochezia (HP:0002573) | 2.48210624 |
69 | Disinhibition (HP:0000734) | 2.47232973 |
70 | Purpura (HP:0000979) | 2.46697594 |
71 | Recurrent lower respiratory tract infections (HP:0002783) | 2.44668054 |
72 | Loss of speech (HP:0002371) | 2.39811457 |
73 | Eosinophilia (HP:0001880) | 2.39030262 |
74 | Joint swelling (HP:0001386) | 2.38538678 |
75 | Chest pain (HP:0100749) | 2.37644836 |
76 | Gingival bleeding (HP:0000225) | 2.37638198 |
77 | Osteomyelitis (HP:0002754) | 2.37007469 |
78 | Hemoptysis (HP:0002105) | 2.36362468 |
79 | Abnormality of the pericardium (HP:0001697) | 2.36025401 |
80 | Vertigo (HP:0002321) | 2.35873379 |
81 | Polyneuropathy (HP:0001271) | 2.34689328 |
82 | Petechiae (HP:0000967) | 2.33749142 |
83 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.33720262 |
84 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.33720262 |
85 | Abnormality of glycolipid metabolism (HP:0010969) | 2.33720262 |
86 | Abnormality of T cell number (HP:0011839) | 2.32206985 |
87 | Nephritis (HP:0000123) | 2.30561435 |
88 | Esophageal neoplasm (HP:0100751) | 2.29328076 |
89 | Neoplasm of head and neck (HP:0012288) | 2.29328076 |
90 | Cheilitis (HP:0100825) | 2.28994227 |
91 | Hepatosplenomegaly (HP:0001433) | 2.28308653 |
92 | Arterial thrombosis (HP:0004420) | 2.28298584 |
93 | Acne (HP:0001061) | 2.25205558 |
94 | Glomerulopathy (HP:0100820) | 2.24951933 |
95 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.23304535 |
96 | Myocardial infarction (HP:0001658) | 2.22790077 |
97 | Vertebral compression fractures (HP:0002953) | 2.22560006 |
98 | Glomerulonephritis (HP:0000099) | 2.20147902 |
99 | Keratitis (HP:0000491) | 2.20038553 |
100 | Meningitis (HP:0001287) | 2.19490511 |
101 | Lower limb hyperreflexia (HP:0002395) | 2.15464756 |
102 | Plagiocephaly (HP:0001357) | 2.13353961 |
103 | Increased serum ferritin (HP:0003281) | 2.13160297 |
104 | Progressive visual loss (HP:0000529) | 2.11389973 |
105 | Parakeratosis (HP:0001036) | 2.10886393 |
106 | Bone pain (HP:0002653) | 2.07626252 |
107 | Abnormality of the peritoneum (HP:0002585) | 2.06792014 |
108 | Abnormality of the basal ganglia (HP:0002134) | 2.06660073 |
109 | Progressive neurologic deterioration (HP:0002344) | 2.05798783 |
110 | Anorexia (HP:0002039) | 2.05578381 |
111 | Peritonitis (HP:0002586) | 2.03005583 |
112 | Skin ulcer (HP:0200042) | 2.02174545 |
113 | Granulocytopenia (HP:0001913) | 2.01925642 |
114 | Abnormality of the pleura (HP:0002103) | 2.01608327 |
115 | Keratoconjunctivitis sicca (HP:0001097) | 2.01424406 |
116 | IgA deficiency (HP:0002720) | 2.01298590 |
117 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.01223887 |
118 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.01223887 |
119 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.01223887 |
120 | Abnormality of the prostate (HP:0008775) | 2.01220623 |
121 | Dysostosis multiplex (HP:0000943) | 1.99546971 |
122 | Prolonged neonatal jaundice (HP:0006579) | 1.98816644 |
123 | Abnormality of T cell physiology (HP:0011840) | 1.98645966 |
124 | Abnormality of eosinophils (HP:0001879) | 1.98348408 |
125 | Arthralgia (HP:0002829) | 1.97880748 |
126 | Abnormality of T cells (HP:0002843) | 1.95746354 |
127 | Inflammation of the large intestine (HP:0002037) | 1.92299827 |
128 | Thrombophlebitis (HP:0004418) | 1.92169064 |
129 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.91012491 |
130 | Mucopolysacchariduria (HP:0008155) | 1.91012491 |
131 | Memory impairment (HP:0002354) | 1.90070395 |
132 | Hypochromic anemia (HP:0001931) | 1.89971952 |
133 | Hemorrhage of the eye (HP:0011885) | 1.88990795 |
134 | Epistaxis (HP:0000421) | 1.88670118 |
135 | Mutism (HP:0002300) | 1.88423810 |
136 | Amaurosis fugax (HP:0100576) | 1.87852741 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PBK | 5.14103204 |
2 | TYK2 | 4.51103593 |
3 | MAP3K14 | 4.46572800 |
4 | TBK1 | 4.10255977 |
5 | IKBKE | 3.74554613 |
6 | RIPK4 | 3.21754481 |
7 | JAK3 | 3.05084311 |
8 | BLK | 2.98902607 |
9 | JAK1 | 2.95716986 |
10 | IRAK4 | 2.93216968 |
11 | PIM2 | 2.60138230 |
12 | MAP3K13 | 2.46388475 |
13 | KIT | 2.41246014 |
14 | IKBKB | 2.31731930 |
15 | FGFR4 | 2.22520898 |
16 | PRPF4B | 2.14247672 |
17 | MAP2K3 | 1.97548042 |
18 | IRAK3 | 1.95834162 |
19 | TAOK2 | 1.83990042 |
20 | ARAF | 1.83290044 |
21 | TXK | 1.75763450 |
22 | MAP3K3 | 1.74540443 |
23 | ERN1 | 1.66241271 |
24 | MAP4K1 | 1.63028528 |
25 | CSK | 1.61299344 |
26 | TAOK1 | 1.60693853 |
27 | EPHB1 | 1.56448056 |
28 | EPHA3 | 1.52072884 |
29 | FGFR3 | 1.44069365 |
30 | MAP3K11 | 1.41095412 |
31 | BMPR2 | 1.37722805 |
32 | CHUK | 1.37547081 |
33 | MATK | 1.32776559 |
34 | SYK | 1.31158292 |
35 | MST4 | 1.30255799 |
36 | NEK9 | 1.21285246 |
37 | ZAP70 | 1.19136647 |
38 | HCK | 1.17402481 |
39 | BMX | 1.17118408 |
40 | EIF2AK2 | 1.15272367 |
41 | MAP3K5 | 1.13227413 |
42 | IRAK1 | 1.11997171 |
43 | TNK2 | 1.10872166 |
44 | FGR | 1.05072664 |
45 | RPS6KA4 | 1.03064743 |
46 | JAK2 | 1.00583696 |
47 | STK4 | 0.95813284 |
48 | MARK3 | 0.95579631 |
49 | ABL2 | 0.94457641 |
50 | LYN | 0.93946342 |
51 | LCK | 0.93381515 |
52 | CDC42BPA | 0.92837861 |
53 | PIM1 | 0.92382992 |
54 | SIK3 | 0.89592738 |
55 | MST1R | 0.82871584 |
56 | NME2 | 0.80118484 |
57 | FES | 0.74133589 |
58 | IRAK2 | 0.71187548 |
59 | HIPK2 | 0.70825777 |
60 | PRKCD | 0.64656995 |
61 | TAOK3 | 0.64459338 |
62 | TRPM7 | 0.63614310 |
63 | GRK6 | 0.63386499 |
64 | CSF1R | 0.62031658 |
65 | ERBB3 | 0.60236188 |
66 | PRKCQ | 0.59108822 |
67 | EGFR | 0.57718580 |
68 | PLK2 | 0.57635925 |
69 | BCR | 0.56596311 |
70 | MOS | 0.55678639 |
71 | ABL1 | 0.55362976 |
72 | BTK | 0.54695390 |
73 | CLK1 | 0.54571550 |
74 | DYRK3 | 0.54488222 |
75 | SIK2 | 0.51416525 |
76 | ITK | 0.50510829 |
77 | RIPK1 | 0.47705802 |
78 | TESK1 | 0.47621881 |
79 | STK10 | 0.46862214 |
80 | MAPK7 | 0.45776896 |
81 | MAP3K9 | 0.45429017 |
82 | STK3 | 0.44612087 |
83 | MAP3K6 | 0.44372365 |
84 | YES1 | 0.43167334 |
85 | DAPK3 | 0.42638594 |
86 | RPS6KA5 | 0.40866023 |
87 | GRK7 | 0.40441735 |
88 | MARK2 | 0.38572600 |
89 | ACVR1B | 0.38221166 |
90 | TEC | 0.38186794 |
91 | TRIB3 | 0.36550804 |
92 | MAP2K6 | 0.36021213 |
93 | PRKD2 | 0.35697500 |
94 | TESK2 | 0.33803074 |
95 | MAP3K1 | 0.33232652 |
96 | DYRK1B | 0.31670335 |
97 | TTN | 0.31607790 |
98 | NLK | 0.28321494 |
99 | MAPKAPK2 | 0.27349989 |
100 | CDK6 | 0.27170681 |
101 | ADRBK2 | 0.26986784 |
102 | LRRK2 | 0.26626461 |
103 | TGFBR2 | 0.26457897 |
104 | PKN1 | 0.26096979 |
105 | DAPK2 | 0.25469420 |
106 | KSR2 | 0.25065338 |
107 | FYN | 0.24629667 |
108 | CAMKK2 | 0.24277228 |
109 | PIK3CG | 0.23366754 |
110 | MAPK11 | 0.21401197 |
111 | MAP3K2 | 0.20232683 |
112 | PDGFRB | 0.20133247 |
113 | RAF1 | 0.19824781 |
114 | PRKCE | 0.19719023 |
115 | SRC | 0.18797572 |
116 | KSR1 | 0.18682070 |
117 | PTK6 | 0.18141542 |
118 | IGF1R | 0.18132522 |
119 | INSR | 0.17866380 |
120 | PDPK1 | 0.16459987 |
121 | SGK3 | 0.15933307 |
122 | ALK | 0.13937589 |
123 | ERBB4 | 0.13512683 |
124 | BRAF | 0.11416637 |
125 | PDK1 | 0.11156425 |
126 | MAPK4 | 0.11147665 |
127 | DDR2 | 0.10906630 |
128 | RPS6KA1 | 0.10133946 |
129 | PRKG2 | 0.09064898 |
130 | MAP3K10 | 0.08060495 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.57984528 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.49796363 |
3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.46731454 |
4 | Allograft rejection_Homo sapiens_hsa05330 | 3.34613306 |
5 | Leishmaniasis_Homo sapiens_hsa05140 | 3.13468780 |
6 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 3.10692584 |
7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.75412045 |
8 | Measles_Homo sapiens_hsa05162 | 2.60197251 |
9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.58829194 |
10 | Influenza A_Homo sapiens_hsa05164 | 2.56679629 |
11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.43607090 |
12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.28286562 |
13 | Pertussis_Homo sapiens_hsa05133 | 2.27858713 |
14 | Malaria_Homo sapiens_hsa05144 | 2.25115583 |
15 | Legionellosis_Homo sapiens_hsa05134 | 2.24076139 |
16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.23763330 |
17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.17403343 |
18 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.11861291 |
19 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.10588622 |
20 | Asthma_Homo sapiens_hsa05310 | 2.07200290 |
21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.95451267 |
22 | Tuberculosis_Homo sapiens_hsa05152 | 1.93365451 |
23 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.91186716 |
24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.87569715 |
25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.78661284 |
26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.66471143 |
27 | Salmonella infection_Homo sapiens_hsa05132 | 1.61180268 |
28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.50736385 |
29 | Hepatitis C_Homo sapiens_hsa05160 | 1.47938095 |
30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.45080418 |
31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.42158500 |
32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.39907975 |
33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39672626 |
34 | Phagosome_Homo sapiens_hsa04145 | 1.39186089 |
35 | Lysosome_Homo sapiens_hsa04142 | 1.34403476 |
36 | Apoptosis_Homo sapiens_hsa04210 | 1.31712241 |
37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.31627276 |
38 | Hepatitis B_Homo sapiens_hsa05161 | 1.20737282 |
39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.18096995 |
40 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.16005789 |
41 | Shigellosis_Homo sapiens_hsa05131 | 1.12566073 |
42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.11254686 |
43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.04980869 |
44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94084853 |
45 | Prion diseases_Homo sapiens_hsa05020 | 0.90956811 |
46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90349525 |
47 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89892221 |
48 | Amoebiasis_Homo sapiens_hsa05146 | 0.85298137 |
49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.81867963 |
50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73781316 |
51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73183810 |
52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72123410 |
53 | Proteasome_Homo sapiens_hsa03050 | 0.59344545 |
54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58791292 |
55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58213459 |
56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55403181 |
57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.54779538 |
58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52919750 |
59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51160084 |
60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51015662 |
61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48817282 |
62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48535402 |
63 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.47376189 |
64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47312896 |
65 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47255229 |
66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46587974 |
67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.46300883 |
68 | Bladder cancer_Homo sapiens_hsa05219 | 0.45847074 |
69 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45392111 |
70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.44454087 |
71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41018375 |
72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40138740 |
73 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39769736 |
74 | Platelet activation_Homo sapiens_hsa04611 | 0.39670215 |
75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37458855 |
76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36263165 |
77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36079748 |
78 | Mineral absorption_Homo sapiens_hsa04978 | 0.35532801 |
79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34575703 |
80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34280170 |
81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.33981665 |
82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33582061 |
83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32611505 |
84 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32151910 |
85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31357381 |
86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29616191 |
87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28445443 |
88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.24152580 |
89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23412887 |
90 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.23265948 |
91 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.23152026 |
92 | HTLV-I infection_Homo sapiens_hsa05166 | 0.20379177 |
93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.17508594 |
94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.15120018 |
95 | Prostate cancer_Homo sapiens_hsa05215 | 0.15072449 |
96 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.14847162 |
97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.14340140 |
98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.13468965 |
99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.12856564 |
100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.12201622 |
101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.11890386 |
102 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.11712291 |
103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.11621079 |
104 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.10926904 |
105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.09318872 |
106 | Insulin resistance_Homo sapiens_hsa04931 | 0.07863547 |
107 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.07862884 |
108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.06514790 |
109 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.06195531 |
110 | Endocytosis_Homo sapiens_hsa04144 | 0.05721028 |
111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.04159194 |
112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.02276186 |
113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.01354044 |